Penicillamine-induced cupriuria in normal subjects and in patients with active liver disease.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D002570:Ceruloplasmin / Q000032:analysis; D056486:Chemical and Drug Induced Liver Injury / Q000652:urine; D002908:Chronic Disease; D003300:Copper / Q000097:blood / Q000652:urine*; D005260:Female; D006505:Hepatitis / Q000652:urine; D006527:Hepatolenticular Degeneration / Q000652:urine; D006801:Humans; D008103:Liver Cirrhosis / Q000652:urine; D008107:Liver Diseases / Q000097:blood / Q000201:enzymology / Q000652:urine*; D008297:Male; D010396:Penicillamine / Q000008:administration & dosage / Q000494:pharmacology*; D012737:Sex Factors
D003300:Copper; D002570:Ceruloplasmin; D001219:Aspartate Aminotransferases; D010396:Penicillamine; D001663:Bilirubin